Patent: 10,036,759
✉ Email this page to a colleague
Summary for Patent: 10,036,759
Title: | Pathway specific markers for diagnosing irritable bowel syndrome |
Abstract: | The present invention provides methods for aiding in the diagnosis of irritable bowel syndrome (IBS) in an individual. In particular, the present invention is useful for determining whether the individual does not have either celiac disease or inflammatory bowel disease (IBD), and has IBS and/or a subtype thereof. Thus, the present invention provides an accurate diagnostic prediction of IBS and is useful for guiding treatment decisions. |
Inventor(s): | Westin; Stefan (Carlsbad, CA), Selvaraj; Fabiyola (San Diego, CA), Princen; Fred (La Jolla, CA), Singh; Sharat (Rancho Santa Fe, CA) |
Assignee: | Nestec S.A. (Vevey, CH) |
Application Number: | 15/646,838 |
Patent Claims: | see list of patent claims |
Details for Patent 10,036,759
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2033-05-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |